SCHEMBL12355679

SCHEMBL12355679

CCC1Cc2ccc(NC(C)=O)cc2C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.50
HTR2C P28335 2/20 0.50
HTR2B P41595 2/20 0.50
ADRA2A P08913 1/20 0.50
MAOA P21397 1/20 0.50
SLC6A2 P23975 1/20 0.50
SLC6A4 P31645 1/20 0.50
RAB9A P51151 4/20 0.47
NPC1 O15118 2/20 0.47
BAZ2B Q9UIF8 1/20 0.46
MTNR1A P48039 1/20 0.45
POLB P06746 2/20 0.44
NR4A1 P22736 1/20 0.44
CYP2C19 P33261 2/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
HPGD P15428 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HTR2A P28223 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12355697 0.88 FYN (0.50) CYP1A2HTR2CHTR2BADRA2AMAOA
SCHEMBL5582685 0.84 MCHR1 (0.54) CYP1A2HTR2CHTR2BADRA2AMAOA
SCHEMBL2250545 0.82 CYP1A2 (0.46) CYP1A2HTR2CHTR2BADRA2AMAOA
SCHEMBL8706424 0.82 PPID (0.43) CYP1A2HTR2CHTR2BADRA2AMAOA
SCHEMBL2246315 0.82 CYP1A2 (0.54) CYP1A2HTR2CHTR2BADRA2AMAOA
SCHEMBL2246016 0.80 CYP1A2 (0.44) CYP1A2HTR2CHTR2BADRA2AMAOA
SCHEMBL8669883 0.79 CA1 (0.60) CYP1A2HTR2CHTR2BADRA2AMAOA
SCHEMBL23519580 0.78 HTR2C (0.50) CYP1A2HTR2CHTR2BADRA2AMAOA
SCHEMBL25086307 0.78 HTR2C (0.50) CYP1A2HTR2CHTR2BADRA2AMAOA
SCHEMBL2249768 0.78 HTR2C (0.50) CYP1A2HTR2CHTR2BADRA2AMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989451-B2 Tricyclic 1,2,4-triazine oxides and compositions for therapeutic use in cancer treatments AUCKLAND UNISERVICES LIMITED (NZ) 2011-08-02 US disclosed